Keywords:
сахарный диабет 1 типа; дети; COVID-19; миокардит; антимиокардиальные антитела; кардиоваскулярные осложнения.References
Law Y.M., Lal A.K., Chen S., et al. Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association. Circulation. 2021;144:e123–e135.
Siripanthong B., Nazarian S., Muser D., et al. Recognizing COVID-19–related myocarditis: Pathophysiology and proposed diagnostic approach. Heart Rhythm. 2020;17(9):1463–1471.
Parra-Lucares A., Segura-Salazar J., et al. Molecular mimicry and cardiac injury associated with SARS-CoV-2 infection. Viruses. 2021;13(12): 2493.
Ammirati E., et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy in the COVID-19 era. European Heart Journal. 2022;43:2043–2053.
Patel H., et al. Evaluation of Autoantibody Binding to Cardiac Tissue in MIS-C and COVID-19–related myocarditis. JAMA Network Open. 2023;6(5).
Silva L.S., et al. Post-COVID myocarditis with anti-heart antibodies persistence. Clinical Cardiology. 2023;46(3):350–351.
Gopinathannair R., et al. Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association. Circulation. 2024;150:e449–e465.
Gogan A., et al. Cardiac Autonomic Neuropathy in Diabetes Mellitus: Current Perspectives. Journal of Clinical Medicine. 2025;14(3):671.
Gözüküçük D., et al. Evaluation of cardiac autonomic dysfunctions in children with type 1 diabetes mellitus. BMC Pediatrics. 2024;24:112.
Atkinson M.A., et al. Update on immune mechanisms in type 1 diabetes. Nature Reviews Endocrinology. 2021;17:195–210.